Hc Advisors, LLC Tg Therapeutics, Inc. Transaction History

Hc Advisors, LLC

  • $117 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$4.57 - $8.4 $52,555 - $96,600
11,500 New
11,500 $68,000
Q1 2021

May 07, 2021
SELL
$41.61 - $54.3 $534,022 - $696,886
-12,834 Closed
0 $0
Q4 2020

Feb 08, 2021
BUY
$25.27 - $54.9 $324,315 - $704,586
12,834 New
12,834 $668,000

Others Institutions Holding TGTX

# of Institutions
338
Shares Held
88.3M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.29B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Hc Advisors, LLC Portfolio

Follow Hc Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hc Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hc Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email